{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T15:28:04Z","timestamp":1794065284161,"version":"4.8.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1038\/s41584-019-0244-4","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T13:02:57Z","timestamp":1561726977000},"page":"503-508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["The structure, specificity and function of anti-citrullinated protein antibodies"],"prefix":"10.1038","volume":"15","author":[{"given":"Changrong","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4969-2576","authenticated-orcid":false,"given":"Rikard","family":"Holmdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,28]]},"reference":[{"key":"244_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3181\/00379727-68-16375","volume":"68","author":"HM Rose","year":"1948","unstructured":"Rose, H. M. & Ragan, C. Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc. Soc. Exp. Biol. Med. 68, 1\u20136 (1948).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"244_CR2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","volume":"101","author":"GA Schellekens","year":"1998","unstructured":"Schellekens, G. A., de Jong, B. A., van den Hoogen, F. H., van de Putte, L. B. & van Venrooij, W. J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 101, 273\u2013281 (1998).","journal-title":"J. Clin. Invest."},{"key":"244_CR3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.162.1.585","volume":"162","author":"E Girbal-Neuhauser","year":"1999","unstructured":"Girbal-Neuhauser, E. et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J. Immunol. 162, 585\u2013594 (1999).","journal-title":"J. Immunol."},{"key":"244_CR4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/art.1780280503","volume":"28","author":"K Aho","year":"1985","unstructured":"Aho, K. et al. When does rheumatoid disease start? Arthritis Rheum. 28, 485\u2013489 (1985).","journal-title":"Arthritis Rheum."},{"key":"244_CR5","first-page":"2743","volume":"27","author":"K Aho","year":"2000","unstructured":"Aho, K. et al. Antifilaggrin antibodies within \u201cnormal\u201d range predict rheumatoid arthritis in a linear fashion. J. Rheumatol. 27, 2743\u20132746 (2000).","journal-title":"J. Rheumatol."},{"key":"244_CR6","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantapaa-Dahlqvist","year":"2003","unstructured":"Rantapaa-Dahlqvist, S. et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 48, 2741\u20132749 (2003).","journal-title":"Arthritis Rheum."},{"key":"244_CR7","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62, 2569\u20132581 (2010).","journal-title":"Arthritis Rheum."},{"key":"244_CR8","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2003.017574","volume":"63","author":"L De Rycke","year":"2004","unstructured":"De Rycke, L. et al. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann. Rheum. Dis. 63, 1587\u20131593 (2004).","journal-title":"Ann. Rheum. Dis."},{"key":"244_CR9","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar1149","volume":"6","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar, E. R. et al. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res. Ther. 6, R142\u2013R150 (2004).","journal-title":"Arthritis Res. Ther."},{"key":"244_CR10","doi-asserted-by":"crossref","first-page":"R1421","DOI":"10.1186\/ar1845","volume":"7","author":"A Kinloch","year":"2005","unstructured":"Kinloch, A. et al. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res. Ther. 7, R1421\u2013R1429 (2005).","journal-title":"Arthritis Res. Ther."},{"key":"244_CR11","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1002\/art.23936","volume":"58","author":"K Lundberg","year":"2008","unstructured":"Lundberg, K. et al. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum. 58, 3009\u20133019 (2008).","journal-title":"Arthritis Rheum."},{"key":"244_CR12","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/eji.200526000","volume":"35","author":"H Burkhardt","year":"2005","unstructured":"Burkhardt, H. et al. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. Eur. J. Immunol. 35, 1643\u20131652 (2005).","journal-title":"Eur. J. Immunol."},{"key":"244_CR13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-065X.1992.tb00832.x","volume":"128","author":"I Randen","year":"1992","unstructured":"Randen, I. et al. Rheumatoid factor V genes from patients with rheumatoid arthritis are diverse and show evidence of an antigen-driven response. Immunol. Rev. 128, 49\u201371 (1992).","journal-title":"Immunol. Rev."},{"key":"244_CR14","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/eji.201444486","volume":"44","author":"R Holmdahl","year":"2014","unstructured":"Holmdahl, R., Malmstrom, V. & Burkhardt, H. Autoimmune priming, tissue attack and chronic inflammation - the three stages of rheumatoid arthritis. Eur. J. Immunol. 44, 1593\u20131599 (2014).","journal-title":"Eur. J. Immunol."},{"key":"244_CR15","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","volume":"108","author":"J Shi","year":"2011","unstructured":"Shi, J. et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc. Natl Acad. Sci. USA 108, 17372\u201317377 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"244_CR16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/rheumatology\/kes371","volume":"52","author":"LA van de Stadt","year":"2013","unstructured":"van de Stadt, L. A. et al. Monoclonal anti-citrullinated protein antibodies selected on citrullinated fibrinogen have distinct targets with different cross-reactivity patterns. Rheumatology 52, 631\u2013635 (2013).","journal-title":"Rheumatology"},{"key":"244_CR17","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1136\/annrheumdis-2015-208356","volume":"75","author":"E Corsiero","year":"2016","unstructured":"Corsiero, E. et al. Single cell cloning and recombinant monoclonal antibodies generation from RA synovial B cells reveal frequent targeting of citrullinated histones of NETs. Ann. Rheum. Dis. 75, 1866\u20131875 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"244_CR18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/art.40699","volume":"71","author":"J Steen","year":"2019","unstructured":"Steen, J. et al. Recognition of amino acid motifs, rather than specific proteins, by human plasma cell-derived monoclonal antibodies to posttranslationally modified proteins in rheumatoid arthritis. Arthritis Rheumatol. 71, 196\u2013209 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"244_CR19","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/annrheumdis-2017-212583","volume":"77","author":"RD Vergroesen","year":"2018","unstructured":"Vergroesen, R. D. et al. B cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation. Ann. Rheum. Dis. 77, 956\u2013958 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"244_CR20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.40698","volume":"71","author":"C Ge","year":"2019","unstructured":"Ge, C. et al. Structural basis of cross-reactivity of anti-citrullinated protein antibodies. Arthritis Rheumatol. 71, 210\u2013221 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"244_CR21","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1136\/ard.2005.044743","volume":"65","author":"Y Takizawa","year":"2006","unstructured":"Takizawa, Y. et al. Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids. Ann. Rheum. Dis. 65, 1013\u20131020 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"244_CR22","volume":"11","author":"NH Trier","year":"2016","unstructured":"Trier, N. H. et al. Physical characteristics of a citrullinated pro-filaggrin epitope recognized by anti-citrullinated protein antibodies in rheumatoid arthritis sera. PLOS ONE 11, e0168542 (2016).","journal-title":"PLOS ONE"},{"key":"244_CR23","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.4049\/jimmunol.1800330","volume":"201","author":"M Cornillet","year":"2018","unstructured":"Cornillet, M. et al. Seropositivity and antibody profiling of patients are dramatically impacted by the features of peptides used as immunosorbents: a lesson from anti-citrullinated protein\/peptide antibody. J. Immunol. 201, 3211\u20133217 (2018).","journal-title":"J. Immunol."},{"key":"244_CR24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.0105-2896.2009.00853.x","volume":"233","author":"H Uysal","year":"2010","unstructured":"Uysal, H. et al. Antibodies to citrullinated proteins: molecular interactions and arthritogenicity. Immunol. Rev. 233, 9\u201333 (2010).","journal-title":"Immunol. Rev."},{"key":"244_CR25","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/annrheumdis-2014-206598","volume":"75","author":"Y Rombouts","year":"2016","unstructured":"Rombouts, Y. et al. Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis. Ann. Rheum. Dis. 75, 578\u2013585 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"244_CR26","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/art.38383","volume":"66","author":"S Haag","year":"2014","unstructured":"Haag, S. et al. Identification of new citrulline-specific autoantibodies, which bind to human arthritic cartilage, by mass spectrometric analysis of citrullinated type II collagen. Arthritis Rheumatol. 66, 1440\u20131449 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"244_CR27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1084\/jem.20081862","volume":"206","author":"H Uysal","year":"2009","unstructured":"Uysal, H. et al. Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J. Exp. Med. 206, 449\u2013462 (2009).","journal-title":"J. Exp. Med."},{"key":"244_CR28","doi-asserted-by":"crossref","first-page":"93688","DOI":"10.1172\/jci.insight.93688","volume":"2","author":"C Ge","year":"2017","unstructured":"Ge, C. et al. Anti-citrullinated protein antibodies cause arthritis by cross-reactivity to joint cartilage. JCI Insight 2, 93688 (2017).","journal-title":"JCI Insight"},{"key":"244_CR29","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.3389\/fimmu.2018.03033","volume":"9","author":"KA Lloyd","year":"2018","unstructured":"Lloyd, K. A. et al. Differential ACPA binding to nuclear antigens reveals a PAD-independent pathway and a distinct subset of acetylation cross-reactive autoantibodies in rheumatoid arthritis. Front. Immunol. 9, 3033 (2018).","journal-title":"Front. Immunol."},{"key":"244_CR30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/annrheumdis-2013-203947","volume":"74","author":"AH Hensvold","year":"2015","unstructured":"Hensvold, A. H. et al. Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins. Ann. Rheum. Dis. 74, 375\u2013380 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"244_CR31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/annrheumdis-2015-208980","volume":"76","author":"AH Hensvold","year":"2017","unstructured":"Hensvold, A. H. et al. How well do ACPA discriminate and predict RA in the general population: a study based on 12 590 population-representative Swedish twins. Ann. Rheum. Dis. 76, 119\u2013125 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"244_CR32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0060001","volume":"6","author":"F Humby","year":"2009","unstructured":"Humby, F. et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLOS Med. 6, e1 (2009).","journal-title":"PLOS Med."},{"key":"244_CR33","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-212568","volume":"77","author":"A Visser","year":"2018","unstructured":"Visser, A., Hamza, N., Kroese, F. G. M. & Bos, N. A. Acquiring new N-glycosylation sites in variable regions of immunoglobulin genes by somatic hypermutation is a common feature of autoimmune diseases. Ann. Rheum. Dis. 77, e69 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"244_CR34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/ard.2009.113092","volume":"69","author":"SW Syversen","year":"2010","unstructured":"Syversen, S. W. et al. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann. Rheum. Dis. 69, 345\u2013351 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"244_CR35","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1136\/ard.2010.146506","volume":"70","author":"HU Scherer","year":"2011","unstructured":"Scherer, H. U. et al. Distinct ACPA fine specificities, formed under the influence of HLA shared epitope alleles, have no effect on radiographic joint damage in rheumatoid arthritis. Ann. Rheum. Dis. 70, 1461\u20131464 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"244_CR36","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI60975","volume":"122","author":"U Harre","year":"2012","unstructured":"Harre, U. et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J. Clin. Invest. 122, 1791\u20131802 (2012).","journal-title":"J. Clin. Invest."},{"key":"244_CR37","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7651","volume":"6","author":"U Harre","year":"2015","unstructured":"Harre, U. et al. Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss. Nat. Commun. 6, 6651 (2015).","journal-title":"Nat. Commun."},{"key":"244_CR38","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1002\/eji.200737581","volume":"37","author":"KS Nandakumar","year":"2007","unstructured":"Nandakumar, K. S. et al. Endoglycosidase treatment abrogates IgG arthritogenicity: importance of IgG glycosylation in arthritis. Eur. J. Immunol. 37, 2973\u20132982 (2007).","journal-title":"Eur. J. Immunol."},{"key":"244_CR39","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/annrheumdis-2015-208093","volume":"75","author":"A Krishnamurthy","year":"2016","unstructured":"Krishnamurthy, A. et al. Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss. Ann. Rheum. Dis. 75, 721\u2013729 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"244_CR40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.2012148612112018r","volume":"216","author":"K Amara","year":"2019","unstructured":"Amara, K. et al. Retraction: monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J. Exp. Med. 216, 245 (2019).","journal-title":"J. Exp. Med."},{"key":"244_CR41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.38273","volume":"66","author":"MJ de Hair","year":"2014","unstructured":"de Hair, M. J. et al. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol. 66, 513\u2013522 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"244_CR42","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/rheumatology\/key220","volume":"58","author":"LE Burgers","year":"2019","unstructured":"Burgers, L. E., Ten Brinck, R. M. & van der Helm-van Mil, A. H. M. Is joint pain in patients with arthralgia suspicious for progression to rheumatoid arthritis explained by subclinical inflammation? A cross-sectional MRI study. Rheumatology 58, 86\u201393 (2019).","journal-title":"Rheumatology"},{"key":"244_CR43","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1002\/art.37686","volume":"64","author":"DB Bas","year":"2012","unstructured":"Bas, D. B. et al. Collagen antibody-induced arthritis evokes persistent pain with spinal glial involvement and transient prostaglandin dependency. Arthritis Rheum. 64, 3886\u20133896 (2012).","journal-title":"Arthritis Rheum."},{"key":"244_CR44","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/s10165-008-0080-x","volume":"18","author":"MJ Rowley","year":"2008","unstructured":"Rowley, M. J., Nandakumar, K. S. & Holmdahl, R. The role of collagen antibodies in mediating arthritis. Mod. Rheumatol. 18, 429\u2013441 (2008).","journal-title":"Mod. Rheumatol."},{"key":"244_CR45","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1186\/ar1989","volume":"8","author":"S Carlsen","year":"2006","unstructured":"Carlsen, S., Nandakumar, K. S. & Holmdahl, R. Type IX collagen deficiency enhances the binding of cartilage-specific antibodies and arthritis severity. Arthritis Res. Ther. 8, R102 (2006).","journal-title":"Arthritis Res. Ther."},{"key":"244_CR46","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3389\/fimmu.2018.01623","volume":"9","author":"KS Nandakumar","year":"2018","unstructured":"Nandakumar, K. S. et al. Streptococcal endo-beta-N-acetylglucosaminidase suppresses antibody-mediated inflammation in vivo. Front. Immunol. 9, 1623 (2018).","journal-title":"Front. Immunol."},{"key":"244_CR47","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/art.1780290314","volume":"29","author":"R Holmdahl","year":"1986","unstructured":"Holmdahl, R., Rubin, K., Klareskog, L., Larsson, E. & Wigzell, H. Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum. 29, 400\u2013410 (1986).","journal-title":"Arthritis Rheum."},{"key":"244_CR48","first-page":"53","volume":"58","author":"R Holmdahl","year":"1988","unstructured":"Holmdahl, R., Jonsson, R., Larsson, P. & Klareskog, L. Early appearance of activated CD4+ T lymphocytes and class II antigen-expressing cells in joints of DBA\/1 mice immunized with type II collagen. Lab Invest. 58, 53\u201360 (1988).","journal-title":"Lab Invest."},{"key":"244_CR49","doi-asserted-by":"publisher","unstructured":"Bersellini Farinotti, A. et al. Cartilage binding antibodies induce pain through immune complex mediated stimulation of neurons. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20181657 (2019).","DOI":"10.1084\/jem.20181657"},{"key":"244_CR50","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.bbi.2011.04.008","volume":"25","author":"L Qu","year":"2011","unstructured":"Qu, L., Zhang, P., LaMotte, R. H. & Ma, C. Neuronal Fc-gamma receptor I mediated excitatory effects of IgG immune complex on rat dorsal root ganglion neurons. Brain Behav. Immun. 25, 1399\u20131407 (2011).","journal-title":"Brain Behav. Immun."},{"key":"244_CR51","doi-asserted-by":"crossref","first-page":"9554","DOI":"10.1523\/JNEUROSCI.6355-11.2012","volume":"32","author":"L Qu","year":"2012","unstructured":"Qu, L. et al. Transient receptor potential canonical 3 (TRPC3) is required for IgG immune complex-induced excitation of the rat dorsal root ganglion neurons. J. Neurosci. 32, 9554\u20139562 (2012).","journal-title":"J. Neurosci."},{"key":"244_CR52","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/annrheumdis-2015-208094corr1","volume":"78","author":"G Wigerblad","year":"2019","unstructured":"Wigerblad, G. et al. Correction: autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism. Ann. Rheum. Dis. 78, 865 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"244_CR53","doi-asserted-by":"crossref","first-page":"R167","DOI":"10.1186\/ar4683","volume":"16","author":"E Ossipova","year":"2014","unstructured":"Ossipova, E. et al. Affinity purified anti-citrullinated protein\/peptide antibodies target antigens expressed in the rheumatoid joint. Arthritis Res. Ther. 16, R167 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"244_CR54","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/art.40590","volume":"70","author":"PJ Titcombe","year":"2018","unstructured":"Titcombe, P. J. et al. Pathogenic citrulline-multispecific B cell receptor clades in rheumatoid arthritis. Arthritis Rheumatol. 70, 1933\u20131945 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"244_CR55","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1084\/jem.20011941","volume":"195","author":"M Maccioni","year":"2002","unstructured":"Maccioni, M. et al. Arthritogenic monoclonal antibodies from K\/BxN mice. J. Exp. Med. 195, 1071\u20131077 (2002).","journal-title":"J. Exp. Med."},{"key":"244_CR56","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1186\/ar4022","volume":"14","author":"H Geng","year":"2012","unstructured":"Geng, H. et al. Cartilage oligomeric matrix protein specific antibodies are pathogenic. Arthritis Res. Ther. 14, R191 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"244_CR57","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11205","volume":"7","author":"Y Ohmi","year":"2016","unstructured":"Ohmi, Y. et al. Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis. Nat. Commun. 7, 11205 (2016).","journal-title":"Nat. Commun."},{"key":"244_CR58","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.intimp.2012.05.007","volume":"13","author":"GM Thiele","year":"2012","unstructured":"Thiele, G. M. et al. Citrullinated mouse collagen administered to DBA\/1J mice in the absence of adjuvant initiates arthritis. Int. Immunopharmacol. 13, 424\u2013431 (2012).","journal-title":"Int. Immunopharmacol."},{"key":"244_CR59","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/cei.12847","volume":"186","author":"M Yamakawa","year":"2016","unstructured":"Yamakawa, M. et al. Porphyromonas gingivalis infection exacerbates the onset of rheumatoid arthritis in SKG mice. Clin. Exp. Immunol. 186, 177\u2013189 (2016).","journal-title":"Clin. Exp. Immunol."},{"key":"244_CR60","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI25422","volume":"116","author":"KA Kuhn","year":"2006","unstructured":"Kuhn, K. A. et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J. Clin. Invest. 116, 961\u2013973 (2006).","journal-title":"J. Clin. Invest."},{"key":"244_CR61","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1186\/ar3520","volume":"13","author":"H Shoda","year":"2011","unstructured":"Shoda, H. et al. Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis. Arthritis Res. Ther. 13, R191 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"244_CR62","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/art.38393","volume":"66","author":"MA Shelef","year":"2014","unstructured":"Shelef, M. A. et al. Peptidylarginine deiminase 4 contributes to tumor necrosis factor alpha-induced inflammatory arthritis. Arthritis Rheumatol. 66, 1482\u20131491 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"244_CR63","doi-asserted-by":"crossref","first-page":"E10169","DOI":"10.1073\/pnas.1713112114","volume":"114","author":"F Arnoux","year":"2017","unstructured":"Arnoux, F. et al. Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types. Proc. Natl Acad. Sci. USA 114, E10169\u2013E10177 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"244_CR64","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13075-016-1143-6","volume":"18","author":"I Sandal","year":"2016","unstructured":"Sandal, I. et al. Bone loss and aggravated autoimmune arthritis in HLA-DRbeta1-bearing humanized mice following oral challenge with Porphyromonas gingivalis. Arthritis Res. Ther. 18, 249 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"244_CR65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102163","volume":"9","author":"JN Stoop","year":"2014","unstructured":"Stoop, J. N. et al. Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis. PLOS ONE 9, e102163 (2014).","journal-title":"PLOS ONE"},{"key":"244_CR66","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fimmu.2017.00362","volume":"8","author":"N Dwivedi","year":"2017","unstructured":"Dwivedi, N. et al. B cell tolerance to deiminated histones in BALB\/c, C57BL\/6, and autoimmune-prone mouse strains. Front. Immunol. 8, 362 (2017).","journal-title":"Front. Immunol."},{"key":"244_CR67","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.4049\/jimmunol.1800826","volume":"201","author":"H Yamada","year":"2018","unstructured":"Yamada, H. et al. Cutting edge: B cells expressing cyclic citrullinated peptide-specific antigen receptor are tolerized in normal conditions. J. Immunol. 201, 3492\u20133496 (2018).","journal-title":"J. Immunol."},{"key":"244_CR68","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.4049\/jimmunol.1101378","volume":"187","author":"D Cao","year":"2011","unstructured":"Cao, D. et al. Pathogenic autoreactive B cells are not negatively selected toward matrix protein collagen II. J. Immunol. 187, 4451\u20134458 (2011).","journal-title":"J. Immunol."},{"key":"244_CR69","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1002\/art.30611","volume":"63","author":"D Dobritzsch","year":"2011","unstructured":"Dobritzsch, D. et al. Crystal structure of an arthritogenic anticollagen immune complex. Arthritis Rheum. 63, 3740\u20133748 (2011).","journal-title":"Arthritis Rheum."},{"key":"244_CR70","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/eji.1830231019","volume":"23","author":"JA Mo","year":"1993","unstructured":"Mo, J. A., Bona, C. A. & Holmdahl, R. Variable region gene selection of immunoglobulin G-expressing B cells with specificity for a defined epitope on type II collagen. Eur. J. Immunol. 23, 2503\u20132510 (1993).","journal-title":"Eur. J. Immunol."},{"key":"244_CR71","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0002-9440(10)63542-0","volume":"163","author":"KS Nandakumar","year":"2003","unstructured":"Nandakumar, K. S., Svensson, L. & Holmdahl, R. Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am. J. Pathol. 163, 1827\u20131837 (2003).","journal-title":"Am. J. Pathol."},{"key":"244_CR72","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.20051951","volume":"203","author":"SB Petkova","year":"2006","unstructured":"Petkova, S. B. et al. Human antibodies induce arthritis in mice deficient in the low-affinity inhibitory IgG receptor Fc gamma RIIB. J. Exp. Med. 203, 275\u2013280 (2006).","journal-title":"J. Exp. Med."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41584-019-0244-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-019-0244-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-019-0244-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T21:08:00Z","timestamp":1694984880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-019-0244-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,28]]},"references-count":72,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["244"],"URL":"https:\/\/doi.org\/10.1038\/s41584-019-0244-4","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,28]]},"assertion":[{"value":"28 May 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors are listed as inventors on a patent application describing the protective effects of ACPA (Holmdahl R, Rispens T, Xu B, Ge C. Antibodies to citrullinated proteins. European Patent office PCT\/EP2018\/082236)","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}